Tyers Asset Management’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Tyers Asset Management’s Portfolio RETA Stock Details RETA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$15K	Hold	192	–	–	﹤0.01%	970
2019 Q2	$18K	Buy	192 +80	+71%	+$6.91K	﹤0.01%	968
2019 Q1	$10K	Sell	112 -32	-22%	-$2.66K	﹤0.01%	973
2018 Q4	$8K	Buy	+144	New	+$8.79K	﹤0.01%	946

Other funds holding RETA

CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Tyers Asset Management's RETA Position: Q3 2019 in Review

Tyers Asset Management held its Reata Pharmaceuticals, Inc. Class A Common Stock (RETA) position steady in Q3 2019 at 192 shares worth $15K. The position accounts for ﹤0.01% of the portfolio, ranked #970.

Tyers Asset Management first reported a position in RETA in Q4 2018 and has held it in 4 quarters since. The position peaked at $18K in Q2 2019. 164 funds tracked by Wall St. Rank hold RETA as of Q3 2019.

Tyers Asset Management held 192 shares of Reata Pharmaceuticals, Inc. Class A Common Stock worth $15K as of Q3 2019.
Tyers Asset Management left its Reata Pharmaceuticals, Inc. Class A Common Stock share count unchanged in Q3 2019.
Reata Pharmaceuticals, Inc. Class A Common Stock made up ﹤0.01% of Tyers Asset Management's portfolio in Q3 2019, its #970 holding.
Tyers Asset Management first reported a position in Reata Pharmaceuticals, Inc. Class A Common Stock in Q4 2018 and has held it in 4 quarters since.
Tyers Asset Management's Reata Pharmaceuticals, Inc. Class A Common Stock position peaked at $18K in Q2 2019.
164 funds tracked by Wall St. Rank held Reata Pharmaceuticals, Inc. Class A Common Stock as of Q3 2019.

Based on Tyers Asset Management's 13F filing for Q3 2019, filed 14 Nov 2019.